Advanced search
Publication Cover
Future Oncology Volume 16, 2020 - Issue 15
Submit an article Journal homepage
4,584
Views
11
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

ENGINE: A Phase III Randomized Placebo Controlled Study of Enzastaurin/R-CHOP as Frontline Therapy in High-Risk Diffuse Large B-Cell Lymphoma Patients with the Genomic Biomarker DGM1

Grzegorz S Nowakowski1 Division of Hematology,Mayo Clinic,Rochester,MN,USAView further author information
,
Jun Zhu2 Peking University Cancer Hospital & Institute,Beijing,PR ChinaCorrespondence[email protected]
View further author information
,
Qingyuan Zhang3 Harbin Medical University Cancer Hospital,Harbin,PR ChinaView further author information
,
Joshua Brody4 Icahn School of Medicine at Mount Sinai,New York,NY,USAView further author information
,
Xiuhua Sun5 The Second Hospital of Dalian Medical University,Dalian,PR ChinaView further author information
,
Joseph Maly6 Norton Cancer Institute,Louisville,KY,USAView further author information
,
Yuqin Song2 Peking University Cancer Hospital & Institute,Beijing,PR ChinaView further author information
,
Syed Rizvi7 University of Texas Southwestern Medical Center,Dallas,TX,USAView further author information
,
Yongping Song8 Affliliated Cancer Hospital of Zhengzhou University,Zhengzhou,PR ChinaView further author information
,
Frederick Lansigan9 Dartmouth-Hitchcock Medical Center,Lebanon,NHView further author information
,
Hongmei Jing10 Peking University Third Hospital,Beijing,PR ChinaView further author information
,
Junning Cao11 Fudan University Shanghai Cancer Center,Shanghai,PR ChinaView further author information
,
Jennifer K Lue12 Columbia University Medical Center, New York,NY,USAView further author information
,
Wen Luo13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Lei Zhang13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Ling Li13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Isabel Han13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Joan Sun13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Manoj Jivani13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Young Liu13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
,
Thomas Heineman13 Denovo Biopharma LLC,San Diego,CA,USAView further author information
&
Stephen D Smith14 University of Washington/Fred Hutchinson Cancer Center,Seattle,WA,USAView further author information
 show all
Pages 991-999 | Received 28 Feb 2020, Accepted 24 Mar 2020, Published online: 06 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.